Editorial: Rifampicin or ethambutol in the routine treatment of tuberculosis.
D002986:Clinical Trials as Topic; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D004977:Ethambutol; D012293:Rifampin